Get started
Author

Hannah Cummings

Observed names: H.E. Cummings, Hannah E Cummings, Hannah E. Cummings, Hannah Elizabeth Cummings
Observed institutions: Brigham and Women's Hospital, Harvard University, The Ohio State University Wexner Medical Center, Alkermes (United States), Kyowa Kirin (United States), The Ohio State University
ORCID: 0009-0009-3570-3148
Observed ORCID: 0009-0009-3570-3148
OpenAlex ID: A5112636740
Cytokines and Their STATs in Cutaneous and Visceral Leishmaniasis
2010 · Hannah E. Cummings, Rashmi Tuladhar, et al. · BioMed Research International · 69
PDF
Characterization of Cross-Protection by Genetically Modified Live-Attenuated Leishmania donovani Parasites against Leishmania mexicana
2014 · Ranadhir Dey, Gayathri Natarajan, et al. · The Journal of Immunology · 55
Cutting Edge: Leukotriene C4 Activates Mouse Platelets in Plasma Exclusively through the Type 2 Cysteinyl Leukotriene Receptor
2013 · Hannah E Cummings, Tao Liu, et al. · The Journal of Immunology · 55
Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis
2012 · Hannah E. Cummings, Joseph Barbi, et al. · Proceedings of the National Academy of Sciences · 53
PDF
Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder
2022 · Michael J. Doane, Leona Bessonova, et al. · BMC Psychiatry · 36
PDF
PI3Kgamma (PI3Kγ) is essential for efficient induction of CXCR3 on activated T cells
2008 · Joseph Barbi, Hannah E. Cummings, et al. · Blood · 30
Role of phosphatidylinositol‐3‐kinase‐γ (PI3Kγ)‐mediated pathway in 17β‐estradiol‐induced killing of L. mexicana in macrophages from C57BL/6 mice
2008 · Claudio M Lezama‐Dávila, Angelica P Isaac‐Márquez, et al. · Immunology and Cell Biology · 24
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
2021 · Leslie Citrome, Christine Graham, et al. · Neuropsychiatric Disease and Treatment · 21
PDF
Opioid antagonism mitigates antipsychotic-associated weight gain: focus on olanzapine
2022 · Roger S. McIntyre, Leslie Citrome, et al. · CNS Spectrums · 15
PDF
Comparative Safety of Istradefylline Among Parkinson Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies
2025 · Yasar Torres-Yaghi, Joyce Qian, et al. · Clinical Neuropharmacology · 8
Adherence and persistence with istradefylline treatment in patients with Parkinson’s disease in the United States
2025 · Reversa Joseph, Joyce Qian, et al. · Frontiers in Pharmacology · 2
PDF
A Combination of Olanzapine and Samidorphan in Adults with Schizophrenia and Bipolar I Disorder: Overview of Clinical Data
2021 · Leslie Citrome, Christine Graham, et al. · CNS Spectrums · 2
PDF
Comparative safety of istradefylline in Parkinson’s disease: A systematic review of randomized controlled trials and real-world studies
2025 · Sagari Betté, Joyce Qian, et al. · Clinical Parkinsonism & Related Disorders · 1
Comparative Safety of Istradefylline Among Parkinson’s Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies (P5-3.017)
2024 · Yasar Torres-Yaghi, Joyce Qian, et al. · Neurology · 1
Opioid Antagonism as a Target for Mitigation of Antipsychotic-Associated Weight Gain
2021 · Roger McIntyre, Leslie Citrome, et al. · Biological Psychiatry · 1
Safety and Efficacy of Istradefylline in Parkinson’s Disease Patients With and Without Preexisting Dyskinesia: Pooled Analysis of 8 Randomized Controlled Trials
2025 · Nobutaka Hattori, Lawrence Elmer, et al. · Journal of Movement Disorders
PDF
Comparative Safety of Istradefylline in Parkinson’s Disease: A Systematic Review of Randomized Controlled Trials and Real-world Studies (P7-5.016)
2025 · Sagari Bette, Joyce Qian, et al. · Neurology
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]
2021 · Leslie Citrome, Christine Graham, et al. · Neuropsychiatric Disease and Treatment
PDF
Weight Gain and Treatment Interruptions with Second-Generation Oral Antipsychotics: Analysis of Patients with Schizophrenia or Bipolar I Disorder
2021 · Michael J. Doane, Leona Bessonova, et al. · CNS Spectrums
PDF
Primary care physicians in an interferon-free world: could safer, more efective oral hepatitis c therapies lead to improved outcomes through education and pcp-prescribed treatment?
2014 · S.R. Levine-Wilkinson, D.W. Holman, et al. · Value in Health
LTC4, But Not LTD4 Or LTE4, Activates Platelets Through a CysLT2R and P2Y12 Receptor-Dependent Pathway
2014 · Joshua A. Boyce, Tao Liu, et al. · Journal of Allergy and Clinical Immunology
PDF
The Role Of Phosphoinositide 3-Kinase Gamma In The Host Immune Response Against Cutaneous Leishmaniasis Caused by Leishmania mexicana
2011 · Hannah Cummings · OhioLink ETD Center (Ohio Library and Information Network)
PDF
Targeting phosphoinositide 3‐kinase γ (PI3Kγ) in the treatment of cutaneous leishmaniasis caused by L. mexicana.
2008 · Hannah Elizabeth Cummings, J. Barbi, et al. · The FASEB Journal
Works count: 23
Citation count: 373
H-index: 9
I10-index: 9
Year
Topic
Type